Abstract Amongst the impulse-control disorders (ICDs) associated with dopamine-replacement therapy in patients with Parkinson's disease (PD) is a repetitive, complex, stereotyped behaviour called punding. Disruption of the reciprocal loops between the striatum and structures in the prefrontal cortex (PFC) following dopamine depletion may predispose patients with PD to these behavioural disorders. The purpose of the present study was to assess the effects of repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral PFC (DLPFC) on punding in PD. We used low-frequency (LF) rTMS in four PD patients presenting with punding. Punding was transiently reversed by LFrTMS over the DLPFC without enhancing motor impairment. The effect was more sustained after right DLPFC rTMS. Therefore, LF-rTMS produced a transient beneficial effect in PD patients with punding, similar to that reported in PD patients with levodopa-induced dyskinesias. rTMS might have therapeutic potential for the treatment of punding and perhaps other ICDs in PD.
Introduction
There is increasing evidence that Parkinson's disease (PD) is associated with disorders in the impulsive-compulsive spectrum, either related to the disease itself, the pharmacological management of the disease or both. These disorders include dopamine dysregulation syndrome, with addictive and stereotyped behaviours, and impulse-control disorders (ICDs) such as pathological gambling, compulsive shopping, binge eating and hypersexuality. A phenomenologically distinct compulsive behaviour known as punding (a complex, stereotypical behaviour characterised by intense fascination for repetitive meaningless movements that are recognised by the patient as disruptive, but that are associated with feelings of calmness or relief) has also been reported in patients with PD who are being treated with dopaminergic therapy (Fernandez and Friedman 1999; Evans et al. 2004; Spencer et al. 2011) . Although the pathophysiology of the underlying mechanisms of the behavioural disorders is not fully understood, disruption of the reciprocal loops between the striatum and structures in the prefrontal cortex (PFC) following dopamine depletion is thought to predispose to them. The inferior frontal gyrus/dorsolateral PFC is important in shifting attention, which contributes to the ability to resist intrusive information such as thinking about drugs/ behaviours (Bechara 2005) ; subjects with ventromedial PFC lesions show characteristic deficits in planning, often repeatedly making decisions that lead to negative consequences (Bechara 2003) . On the other hand, the medial PFC innervates the striatum (in particular, the nucleus accumbens and anteromedial caudate-putamen), and participates in the regulation of subcortical dopaminergic mechanisms (Whishaw et al. 1992; Lipska et al. 1995) .
Another major complication of long-term dopaminergic treatment of PD is dyskinesias. Clinical and preclinical studies suggest that chronic intermittent dopamine receptor agonist treatment is associated with dyskinesias and punding (Silveira-Moriyama et al. 2006) .
Transcranial magnetic stimulation (TMS), a non-invasive means of electrically stimulating neurons in the human cerebral cortex, is able to modify neuronal activity locally and at distant sites when delivered in series or trains of pulses (Pascual-Leone et al. 1998) . Repetitive TMS (rTMS) can be applied as continuous trains of low frequency (1 Hz or less) or bursts of higher frequency (C1 Hz) rTMS; in general, lowfrequency (LF) rTMS and is thought to reduce excitability in the targeted cortical region, while high-frequency rTMS is thought to enhance excitability. In particular, slow rTMS, where one magnetic pulse is applied every second (1 Hz), delivered to the motor cortex can give rise to a lasting decrease in corticospinal excitability (Chen et al. 1997; Maeda et al. 2000) . LF-rTMS to the supplementary motor area has been reported to reduce levodopa-induced dyskinesia, but only for up to 30 min (Koch et al. 2005) . A small open study of LFrTMS over the motor cortex showed a reduction in peak dose dyskinesia, which was measurable and significant a day after the last session (Wagle-Shukla et al. 2007 ). In addition, Filipovic and colleagues (2009) demonstrated residual beneficial clinical after-effects on dyskinesias following consecutive daily applications of LF-rTMS in patients with PD.
The beneficial effects of LF-rTMS on dyskinesias are thought to rely on the transient depression of synaptic excitability at the cortical level or on the promotion of depotentiation at corticostriatal circuits. Based on this assumption, we hypothesised that inhibition of dorsolateral PFC (DLPFC) by LF-rTMS might also modulate motor stereotyped behaviours in PD patients. The DLPFC is a common target for rTMS experiments and therapeutic protocols; in this study, we used LF-rTMS over the DLPFC in four PD patients who showed punding.
Methods

Patients
We studied four patients with PD who developed punding. The demographic and clinical characteristics of the patients are shown in Table 1 . All of the patients developed this peculiar, stereotyped and compulsive behaviour in the absence of significant cognitive impairment or prior psychiatric conditions. The patients recognized that time spent on these activities was excessive and inappropriate, but found it difficult to disengage from the activities. They described these activities as ''very soothing'' and became irritated if they were interrupted, and were sometimes frustrated by their inability to stop these behaviours.
All of the patients were on dopaminergic medication, and were taking no other drugs that could influence cortical excitability. The patients were screened for other ICDs in addition to punding.
Punding was measured using a self-report questionnaire (Lawrence et al. 2007 ) adapted from Evans et al. (2004) ''Punding in Parkinson's Disease''. The adapted questionnaire was scored separately for each activity, giving a Punding Scale Score between 0 and 42, with higher scores indicative of punding. Patients completed the questionnaire (Evans et al. 2004; Lawrence et al. 2007 ) before TMS examination (T0), 1 h (T1), 12 h (T2) and 24 h (T3) after TMS examination.
At the same time points, the patients also completed the Doubting and Hoarding distress subscales of the Obsessive-Compulsive Inventory (OCI) (Foa et al. 1998 ), a selfreport inventory for determining the diagnosis and overall severity of obsessive-compulsive disorder. The psychopathological assessment also included the Hamilton Anxiety Scale (HAM-A) (Hamilton 1959 ) and the Hamilton Depression Rating Scale (HAM-D) (Hamilton 1960) . The motor section of Unified Parkinson's Disease Rating Scale (UPDRS) (Fahn et al. 1987 ) was employed to evaluate the effects of rTMS on motor function.
The control group consisted of nine age-matched healthy control subjects (mean years 65.2 years, range 59-71 years, seven men and two women, all right-handed as were the patients). The control participants were not taking any drugs that could alter cortex excitability.
The patients and the control subjects provided informed consent before participation in the study, which was performed according to the safety application guidelines (Rossi et al. 2009) , and approved by the Ethics Committee.
Transcranial magnetic stimulation
A Rapid Transcranial Magnetic Stimulator (Magstim, Whitland, UK) was used. Real rTMS was carried out using a standard Magstim figure-of-eight coil, while sham rTMS was carried out using a Placebo Coil System (Magstim Company). Three series of 600 stimuli at a rate of 1 Hz, separated by 1-min breaks, were applied during each rTMS session (for a total of 1.800 stimuli, duration 32 min). The stimulator intensity was set to be just below the active motor threshold (AMT). AMT was defined as the minimum stimulus intensity that produced a liminal motor evoked response (about 200 lV in 50 % of 10 trials) during isometric contraction at about 20 % maximum (Rothwell et al. 1999 ). The DLPFC is a broad area; we used a site similar to that used by other research groups using TMS (Epstein et al. 2002; Jones et al. 2004 ). The coil was placed 5 cm anterior from the hand motor area on the left and right hemispheres and held parallel to the midsagittal line. The hand motor area was located by finding the lowest threshold spot for activating the contralateral first dorsal interosseous (FDI) muscle.
The patients and the controls were blinded to real vs sham therapy. Real rTMS with selected intensity did not induce muscle contractions in any of the patients. Patients and control subjects were given real rTMS to the right DLPFC and the left DLPFC and sham rTMS to the right DLPFC on separate days, with an intersession interval of 4 days.
The order of the rTMS treatments was randomly assigned and counterbalanced across subjects. The time of day for treatment visits was kept constant for each patient.
The primary outcome measures were changes in the Punding Scale Score and in scores on the distress subscales of the OCI induced by rTMS, while secondary outcome measures included changes in the HAM-A and HAM-D scores.
Statistical analysis
A two-sample t test for the scores at time T0 was used to assess whether the test scores of the patients were statistically different from those of the control group. For the effect of rTMS stimulation, for each time of examination, we used a two-sample t test for the score differences with respect to time T0 for the four patients versus the nine control subjects. The mean score difference of the patients revealed in which direction (if any) the rTMS affected the patients' scores (either by increasing or decreasing the scores). A p-value of \0.05 was taken as the significant threshold for all individual and multiple comparisons. We also calculated the effect sizes and power for all individual comparisons.
This analysis was performed for each of the six test scores and is based on a normality assumption for the distribution of the scores. To control for non-normality, we replicated the analysis using non-parametric Mann-Whitney tests.
Finally, we investigated the effect of rTMS stimulation on the Punding scale score via a repeated measures analysis of variance (ANOVA). We studied the effect on the score difference y for the 13 subjects of the predictors SITE [factor b j S with categories sham (j = 1), right DLPFC (j = 2) and left DLPFC (j = 3) and TIME (factor b k T with categories T1 (k = 1), T2 (k = 2) and T3 (k = 3)] controlling for the GROUP (indicator variable b l G for the patient' group). We estimate the model with two-and three-way interactions by adding a random intercept for each individual (i = 1,…, 13):
(the superscripts are labels and do not represent power). The effects associated with TIME = 1 SITE = 1 and GROUP = 0 were set to zero (reference levels), a i was independent and identically distributed Gaussian with mean zero and e was the error term.
Results
Punding scale
Each patient was found to have only punding behaviour and no other ICDs. The Punding Scale Score at T0 was Doubting and Hoarding distress rating scores of the OCI The Doubting distress rating score at T0 was significantly higher in the patient group (3.75 ± 0.50) than in the control group (0.22 ± 0.44; p \ 0.0001). After rTMS over the right DLPFC, the Doubting distress rating score of the patients showed a significant decrease at T1 (p \ 0.0001) and T2, while the effect disappeared at T3. After rTMS over the left DLPFC, we observed a decrease in the distress rating score only at T1. No effects were observed after sham stimulation. Similar results were obtained for the Hoarding distress rating score.
HAM-A, HAM-D
The HAM-A score at time T0 was significantly higher in the patient group (18.25 ± 3.50) than in the control group (1.22 ± 1.09; p \ 0.0001). rTMS had no overall effect on the patient group. Similar results were found for the HAM-D and UPDRS.
No side effects or adverse effects on motor function were noted in the patients, as evaluated according to the motor section of the UPDRS (Fahn et al. 1987) . T1-T0  T2-T0  T3-T0  T1-T0  T2-T0  T3-T0  T1-T0  T2-T0  T3- The raw data are displayed in Fig. 1 . Mean scores are reported in Table 2 , together with test results.
Discussion
We found in this study that LF-rTMS can suppress punding, just as it suppresses levodopa-induced dyskinesias in PD. Normal goal-directed behaviour is orchestrated by the striatum, through parallel interconnecting circuits (Alexander et al. 1990 ). The striatum is a mosaic of two compartments, a ventral ''limbic'' part and a dorsal ''sensorimotor'' part. PD patients may develop plastic changes in the striatal matrix leading to hyperkinesias. As soon as these changes are also seen in the striatal striosomes, a stereotyped, non-adaptive, rigid, behaviour (punding) can occur.
Indeed, in an animal model of PD, dopaminergic treatment is thought to prime the dorsal striatal system to respond to a subsequent dopaminergic challenge with both hyperkinesias and repetitive, stereotyped behaviour (Van de Witte et al. 2002) . In monkeys, repeated exposure to cocaine (an animal model of punding) leads to stereotyped behaviour linked to dorsal striatal activation (Saka et al. 2004) . A glutamate receptor antagonist was able to reduce the dorsal striatal overactivation and the associated behaviour abnormalities in this animal PD-model ( Van de Witte et al. 2002) . T1-T0  T2-T0  T3-T0  T1-T0  T2-T0  T3-T0  T1-T0  T2-T0  T3- Glutamatergic projections from the cerebral cortex are known to modulate signal transduction of basal gangliathalamocortical circuits and the sensitised glutamate N-methyl-D-aspartate (NMDA) receptors may also be required to express levodopa-induced dyskinesias and stereotypies (Calon et al. 2003) . The rationale for using LFrTMS is based on the evidence that it induces a long-lasting decrease in motor cortex excitability that might antagonise glutamatergic hypersensitivity by reducing the response of the striatum to glutamatergic excitatory inputs.
Interestingly, the NMDA receptor antagonist amantadine suppresses the expression of levodopa-induced dyskinesias (Metman et al. 1998 ) and has been found to be effective in reducing punding in a PD patient (Kashihara and Imamura 2008) . Moreover, punding is associated with ICDs, according to a recent cross-sectional study (Weintraub et al. 2010) . The treatment of punding is usually based on reducing dopamine replacement therapy, which often results in increased motor disability. In this study, our patients' punding was reversed by rTMS, which did not aggravate motor function.
The fact that PD patients often become anxious, stressed or frustrated when stopped in their compulsive behaviours suggests that emotional/motivational factors are also involved in punding, to a certain degree. It should be noted that all the patients in this study present mild to moderate anxiety; however, LF-rTMS failed to significantly modify the HAM-A score in these patients.
We found significant changes in the Doubting and Hoarding distress subscales of the OCI after LF-rTMS. This finding is in agreement with several lesion, neuroimaging and neuropsychological studies indicating that the cortico-striatal circuitry might have a key role in the pathogenesis of obsessive-compulsive disorders (Graybiel and Rauch 2000; Menzies et al. 2008) . Therefore, another possible interpretation of our results is that LF-rTMS of the DLPFC affects the compulsive aspects of punding (the sense of needing to engage in a behaviour and the relief that arises from engaging in it), and this why the significant results on the punding scale are associated with changes in OCD subscales measures.
A limitation of this study is the small patient sample. However, the present report suggests that LF-rTMS is a promising approach in terms of potential efficacy for the treatment of punding in PD patients and further studies on larger groups of patients are warranted. Our results also confirm that rTMS over the DLPFC is safe and well tolerated; however, the clinical feasibility of this approach for a larger group of patients still needs to be investigated.
In this study, the intervention was acute and the period of symptoms alleviation was very short. Overall, a single session of rTMS mostly lead to transient, short-lived effects-as previously described, for example, in patients with neuropathic pain (Khedr et al. 2005) , PD (Lefaucheur 2006) , or Alzheimer's disease (Freitas et al. 2011) . Repeated applications of rTMS every day for several days (usually 5 or 10 days) may extend the duration of the beneficial effects. Therefore, more robust stimulation protocols, in terms of duration in particular, are needed to better understand the therapeutic role of rTMS for these patients. These preliminary findings might open up a new therapeutic perspective in impulse-compulsive disorders in PD, based on neuromodulation.
